- Home
- DNMX vs GALT Comparison
DNMX vs GALT Comparison
Compare DNMX & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$3.45
Company Overview
Basic Information| Metric | DNMX | GALT |
|---|---|---|
| Founded | 2025 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 265.6M | 297.0M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | DNMX | GALT |
|---|---|---|
| Price | $10.03 | $3.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 10.3K | ★ 528.1K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.87 | $2.03 |
| 52 Week High | $10.04 | $7.13 |
Technical Indicators
Market Signals| Indicator | DNMX | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 55.02 | 43.95 |
| Support Level | $9.99 | $2.75 |
| Resistance Level | $10.03 | $3.35 |
| Average True Range (ATR) | 0.01 | 0.32 |
| MACD | 0.00 | -0.11 |
| Stochastic Oscillator | 50.00 | 28.78 |
Price Performance
Historical Comparison DNMX
GALT
About DNMX Dynamix Corporation III Class A Ordinary Shares
Dynamix Corp III is a blank check company.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.